ICU Medical Inc (ICUI)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -117,688 -111,007 -70,786 -59,314 -29,655 -28,044 -48,490 -46,030 -74,286 -38,825 5,464 41,336 103,135 109,352 103,257 93,767 86,870 81,369 82,946 86,871
Total stockholders’ equity US$ in thousands 1,965,240 2,048,590 2,037,810 2,067,830 2,123,410 2,098,360 2,114,820 2,100,400 2,089,930 2,012,800 2,085,870 2,178,900 1,616,030 1,589,970 1,557,260 1,520,770 1,502,260 1,452,220 1,411,800 1,375,890
ROE -5.99% -5.42% -3.47% -2.87% -1.40% -1.34% -2.29% -2.19% -3.55% -1.93% 0.26% 1.90% 6.38% 6.88% 6.63% 6.17% 5.78% 5.60% 5.88% 6.31%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-117,688K ÷ $1,965,240K
= -5.99%

The return on equity (ROE) for ICU Medical Inc showed a declining trend over the past few years, starting at 6.31% in March 2020 and gradually decreasing to -5.99% by December 2024. The ROE measures the company's ability to generate profits from shareholders' equity, and a negative ROE indicates that the company is not efficiently utilizing its equity to generate profits. The decreasing ROE suggests a decline in profitability relative to the shareholders' investment in the company. This trend raises concerns about the company's ability to generate a satisfactory return for its shareholders and may indicate underlying issues with the company's financial performance and operational efficiency.